Vanguard Asset Management’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.2K Hold
9,535
– – ﹤0.01% 2416
2026
Q2
$419K Buy
+9,535
New +$381K ﹤0.01% 2252

Other funds holding SION

Vanguard Asset Management's SION Position: Q3 2026 in Review

Vanguard Asset Management held its Sionna Therapeutics (SION) position steady in Q3 2026 at 9,535 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Vanguard Asset Management first reported a position in SION in Q2 2026 and has held it in 2 quarters since. The position peaked at $419K in Q2 2026. 136 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Vanguard Asset Management held 9,535 shares of Sionna Therapeutics worth $50.2K as of Q3 2026.
  • Vanguard Asset Management left its Sionna Therapeutics share count unchanged in Q3 2026.
  • Sionna Therapeutics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2416 holding.
  • Vanguard Asset Management first reported a position in Sionna Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Sionna Therapeutics position peaked at $419K in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.